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Abstract Mutations in the human sulphate transporter gene,
DTDST, have been implicated in several diseases. Analysis of
affected patients has linked disease symptoms to faulty sulphate
transporter activity. We have reproduced two of these mutations
in SHST1, a homologous member of the family isolated from the
tropical legume, Stylosanthes hamata. Both mutations signifi-
cantly reduce sulphate transport activity of SHST1. These
results indicate that conserved residues between distinct members
of the family may share essential roles in structure or function.
The results also suggest that putative helix 9 may be important
for stability and/or trafficking of SHST1 to the plasma
membrane. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
High a⁄nity sulphate transporters are members of an ex-
panding family of anion transporters [1] and have been iso-
lated from many di¡erent organisms, including plants, fungi
and mammals. Although most of the characterised members
have been shown to transport sulphate (for example, those
from plants [2], yeast [3] and rat [4]), homologues with other
speci¢cities have recently been found. Three members of this
family have been isolated from humans and are of consider-
able interest for two reasons. Firstly, all three have been im-
plicated in di¡erent diseases and there are now a number of
mutations described from a¡ected patients. Secondly, some of
the human members transport anions other than sulphate and
show di¡erent modes of energisation. For example, pendrin is
a chloride/iodide transporter and mutations in this gene cause
a form of congenital deafness [5]. Similarly, DRA appears to
be a chloride/bicarbonate exchanger and has been implicated
in congenital chloride diarrhoea [6,7].
Mutations in the human DTDST gene, which encodes a
sulphate transporter, cause a series of chondrodysplasias of
di¡ering severity [8,9]. Diastrophic dysplasia was the ¢rst
characterised [8], and appears to be due to extremely low
expression of the DTDST gene [10]. Patients live a normal
life span but show severe skeletal deformities which are
thought to result from undersulphation of proteoglycans [8].
Following isolation of the DTDST gene, patients with related
but more severe chondrodysplasias such as atelosteogenesis
type II and achondrogenesis type 1B were also examined for
mutations in the same gene. Several such mutations have now
been identi¢ed. Biochemical analysis of chondrocytes and ¢-
broblasts from patients indicated that there is very little sul-
phate transport activity in most mutants so far analysed [9^
12]. In their most severe forms, chondrodysplasias are fatal
and many of the mutations responsible for the lethal variants
are frameshifts or altered splice sites, consistent with a com-
plete absence of sulphate transport due to the DTDST pro-
tein. However, there are also some point mutations that show
the severe phenotype. Naturally occurring point mutations
with deleterious e¡ects can sometimes give useful information
for protein structure and function studies. We were interested
to test whether homologous mutations would have similar
e¡ects in another member of the sulphate transporter family.
Our aim in the present work was to characterise the e¡ects of
some of these mutations by using expression of a homologous
sulphate transporter from the tropical legume Stylosanthes
hamata in yeast as a model system. Expression in yeast is
an attractive system for structure^function analysis since yeast
is relatively simple to grow and use for transport studies.
S. hamata possesses three homologous sulphate transport-
ers, two of which have a Km for sulphate of around 10 WM
and the third with a 10-fold lower a⁄nity [2]. Functional
expression of these transporters in yeast was used to isolate
their cDNAs and to characterise the biochemical properties of
the transporters [2]. A comparison of the protein sequences of
DTDST and SHST1, one of the high a⁄nity sulphate trans-
porters from S. hamata, indicates that several of the disease-
causing mutations occur in conserved amino acids. Although
both proteins transport sulphate, they are likely to be ener-
gised di¡erently. DTDST is thought to be a sulphate/chloride
antiporter [8] whereas SHST1 is a proton-coupled symporter
[2]. We aimed to gain information on structure and function
of this family of transporters by reproducing some of the
disease-causing mutations in SHST1 and analysing the prop-
erties of the mutant transporters.
2. Materials and methods
2.1. Molecular biology
Standard procedures were used for bacterial plasmid isolation and
transformation into Escherichia coli. SHST1 in the yeast expression
vector pYES3 [3] was used for site-directed mutagenesis, using the
Quikchange method from Stratagene. Mutagenic oligonucleotides
were 25^30 bases long and included the codon changes shown in
Table 1. The entire shst1 cDNA was sequenced following mutagenesis
to con¢rm that no PCR-derived errors had arisen.
2.2. Yeast growth and transformation
Saccharomyces cerevisiae strain YSD1, which has a deletion in the
native sulphate transporter gene [3], was used for expression of
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SHST1 and the mutants derived from it. Sulphate-free growth me-
dium was prepared as previously described [3] and supplemented with
either 38.26 mg/l homocysteine thiolactone or 100 WM sulphate. For
the growth experiments, yeast cultures were grown at 28‡C, with
shaking. Optical density was measured using a Klett^Summerson cal-
orimeter. Yeast transformation was by a LiCl/PEG method [13].
2.3. Sulphate uptake assays
Sulphate uptake assays were based on those described by Smith et
al. [2,3]. Yeast cells were grown to mid-log phase in sulphate-free
medium minus uracil and supplemented with homocysteine thiolac-
tone and 2% galactose. Cells were then harvested by centrifugation at
5000Ug for 15 min, washed and resuspended in sulphur-free growth
medium, and incubated at 28‡C for 30 min prior to the uptake mea-
surements. Cells (50 Wl) were then incubated with [35S]sodium sulphate
for the times indicated and the reaction stopped by rapid centrifuga-
tion through a silicon oil layer into 5 Wl 40% perchloric acid. The
[35S]sulphate concentration was 50 WM unless otherwise indicated.
Radioactivity in the pellet was determined by liquid scintillation
counting.
2.4. Western blotting of plasma membrane fractions
Yeast cells for plasma membrane preparation were grown to mid-
log phase in sulphate-free medium minus uracil and supplemented
with homocysteine thiolactone and 2% galactose. Cells were lysed
and plasma membranes isolated on a sucrose density gradient follow-
ing the procedure of Katzmann et al. [14]. The level of protein in cell
lysates from each mutant was determined using the BCA1 Protein
Assay Reagent (Pierce) and the concentration adjusted so that a sim-
ilar level of protein was loaded onto each sucrose gradient. Plasma
membrane fractions were harvested and protein was precipitated with
trichloroacetic acid as described by Katzmann et al. [14]. Protein was
then resuspended in sample bu¡er (6.25 mM Tris^HCl pH 6.8, 5%
SDS, 6 M urea, 500 mM dithiothreitol, 10% glycerol and 0.002%
bromophenol blue) and heated at 70‡C for 25 min prior to loading
onto a gel. Proteins were resolved by SDS^PAGE and blotted onto
nitrocellulose using a semidry transfer protocol [15]. Rabbits were
used to raise polyclonal antisera against a 24 kDa C-terminal frag-
ment of SHST1 following standard procedures [16]. Immunoreactive
SHST1 was detected with a horseradish peroxidase-conjugated goat
anti-rabbit IgG (ICN) and enhanced chemiluminescence (Pierce,
SuperSignal1 Substrate).
3. Results
3.1. Sequence alignment and construction of mutants
An alignment of SHST1 with DTDST is shown in Fig. 1.
The primary sequence shows only 24% identity. More exten-
sive sequence analysis has identi¢ed several motifs that are
conserved throughout the entire family [1]. Despite the low
level of sequence homology, the hydropathy plots are clearly
similar and are consistent with the presence of 12 transmem-
brane helices (not shown). This suggests that the overall struc-
ture and perhaps also the sulphate transport pathway are
conserved, despite di¡erences in energisation. Several muta-
tions responsible for chondrodysplasias a¡ect conserved resi-
dues and two such mutations were chosen to study: N425D in
putative helix 9 and L483P in putative helix 11 (Fig. 1). Both
mutations are non-conservative changes, introducing a nega-
tive charge or a helix-breaking residue into putative trans-
membrane regions. Both are also implicated in the most se-
vere disease, achondrogenesis type 1B, which is thought to
result from a complete loss of sulphate transport [10,11].
N425 is in putative transmembrane helix 9 which forms part
of a conserved region that has been identi¢ed as a signature
sequence of this transporter family (see Fig. 1B) [1]. An as-
paragine residue is present at this position in sulphate trans-
porters from all species so far examined with the exception of
Caenorhabditis elegans [1]. The only completely invariant res-
idue in this region is E418 [1]. This residue is predicted to be
located at the N-terminal end of putative helix 9. Because of
its high conservation, this residue is potentially important for
sulphate transporter function.
The equivalent residues in SHST1 are N395, L453 and
E387. Site-directed mutagenesis was used to introduce the
four mutations shown in Table 1. The resulting plasmids car-
ried the mutations: N395D, N395A, L453P and E387Q. The
N395A mutant was constructed in order to compare the ef-
fects of introducing a charged or a non-polar residue into this
position. The mutant plasmids were then transformed into the
sulphate uptake-de¢cient yeast strain YSD1 [3] to give strains
YSD23(N395D), YSD19(N395A), YSD22(L453P) and YSD-
24 (E387Q).
3.2. The e¡ects of mutations in SHST1
The mutant plasmids were tested for their ability to comple-
ment the yeast strain YSD1 on plates containing 100 WM
sulphate with galactose as the carbon source. The N395D
mutation completely abolished complementation while the
mutations L453P, N395A and E387Q did allow complemen-
tation of YSD1 (Table 2). The growth rates in liquid medium
with 100 WM sulphate were also examined (Fig. 2).
YSD22(L453P) grew at a rate comparable to the wild type,
YSD7(SHST1), although the ¢nal cell density was slightly
less. YSD24(E387) took longer to enter exponential phase
than YSD7(SHST1) but then grew at a similar rate. YSD19-
(N395A) grew quite slowly in liquid medium.
Sulphate uptake by each of the mutant strains was deter-
mined and the results are shown in Table 2. YSD23(N395D)
did not have any measurable sulphate uptake activity, consis-
tent with its failure to grow on low sulphate medium. YS-
D24(E387Q), YSD19(N395A) and YSD22(L453P) had low
but signi¢cant levels of sulphate transport. Although YSD19-
(N395A) and YSD24(E387Q) retained only about 15% of the
wild type level of activity, this was su⁄cient for complemen-
tation of YSD1. The concentration dependence of uptake was
determined for the three mutants that did retain some func-
tion. The wild type SHST1 had a Km of 9 WM, which agrees
well with the previously published value of 10 WM [2]. Each of
the three mutations, E387Q, N395A and L453P, resulted in a
slightly lower a⁄nity for sulphate (Table 2). Therefore the
mutations at these positions a¡ect the level of transport ac-
tivity much more than the a⁄nity of the transporter for sul-
phate.
3.3. Determination of the level of expression of SHST1 mutant
proteins in the plasma membrane
The low level of sulphate transport activity observed in all
mutants could result from the loss of function of SHST1 or
from failure of SHST1 to be correctly tra⁄cked to the plasma
membrane. To distinguish between these two alternatives,
plasma membranes from each of the mutant strains were iso-
Table 1
Mutations introduced into SHST1 and the resulting mutant strains
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lated and used for Western blotting as described in Section 2.
Fig. 3 shows the results of this experiment. SHST1 is pre-
dicted to have a molecular weight of 73 kDa but was consis-
tently observed to run at 140 kDa, although a number of
di¡erent sample preparation conditions were tested. SHST1
appears not to fully denature under the running conditions
and therefore may run as a dimer or run aberrantly as a result
of its hydrophobicity. Secondary transporters are usually
thought to function as monomers, although this has not
been investigated for SHST1. None of the mutations com-
pletely abolished plasma membrane expression of SHST1
but only the L453P mutant had a similar level of expression
to the wild type. SHST1 with the L453P mutation ran even
higher than the wild type protein and the band was quite
smeared, presumably because of conformational di¡erences.
Expression of the E387Q mutant was very low and, of the
two changes made at position 395, the N395D mutant had a
lower level of SHST1 protein in the plasma membrane than
the N395A mutant.
4. Discussion
We have characterised four mutations of SHST1, all of
which signi¢cantly a¡ect sulphate uptake activity. Two of
the mutations were designed to mimic changes in the DTDST
gene which have been shown to cause achondrogenesis type
1B [9,11,12]. It has been suggested that this phenotype results
from a complete loss of DTDST function [9]. Both mutations
are non-conservative changes so severe e¡ects were to be ex-
pected. Surprisingly, the two mutations had very di¡erent
e¡ects in SHST1. While YSD22(L453P) did retain some sul-
phate transport activity, the N395D mutation completely
abolished function.
L453 is predicted to occur within putative transmembrane
Fig. 1. A: Alignment of SHST1 and DTDST. Alignment was performed using ClustalW. Identical residues are shaded and those mutated in
this study are indicated by arrows. Putative transmembrane helices are indicated by bars below the sequence. B: The conserved motif around
putative helix 9 identi¢ed by Saier et al. [1].
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helix 11 (Fig. 1) although there is at present no information
on the topology of any member of this anion transporter
family. Leucine is a hydrophobic residue which is a good helix
former. It was replaced by proline which is less hydrophobic
and a helix breaker. The L453P mutation substantially re-
duced the level of sulphate uptake activity of SHST1 but
had only a minor e¡ect on the a⁄nity for sulphate. The
L453P mutant protein was targeted to the plasma membrane
as well as the wild type SHST1 which suggests that no gross
structural defect had occurred as a result of this mutation.
Disruption to the helicity of this region within the membrane,
which may alter the positions of crucial amino acid residues
relative to each other, could account for the reduction in
sulphate transport activity. Information on the topology of
SHST1 is required to con¢rm this interpretation.
The homologous mutation in the DTDST gene, L483P,
appears to completely abolish sulphate transport in chondro-
cytes and ¢broblasts of patients [10,11]. This has been deter-
mined from uptake assays and is suggested by the fact that
patients homozygous for L483P have achondrogenesis type
1B, the most severe chondrodysplasia. It is, therefore, some-
what surprising that the equivalent mutation in SHST1 re-
tained about one third of the wild type activity. This could
be a result of high expression levels from the GAL promoter
in the yeast expression system. As mentioned above, we ob-
served that two mutations were able to complement YSD1
although their sulphate uptake activity was only about 15%
of the wild type. This suggests that the expression level is very
high. The lower expression level of DTDST in chondrocytes
may be insu⁄cient to give measurable sulphate transport ac-
tivity. Alternatively, the di¡erent phenotypes may re£ect func-
tional di¡erences between DTDST and SHST1 since their
primary sequence is only 24% identical and the two trans-
porters are energised di¡erently.
In contrast, the N395D mutation did completely abolish
sulphate transport activity and in this respect behaved simi-
larly to its DTDST counterpart which is also responsible for
achondrogenesis type 1B. A severe e¡ect is also to be expected
with the introduction of a charged residue into a putative
transmembrane helix (helix 9). Expression of the protein in
the plasma membrane was severely reduced but not com-
pletely abolished, suggesting that the N395D mutation a¡ects
both targeting and function of SHST1. Asparagine is a polar
residue so we were interested in whether its polarity was im-
portant for function of SHST1, and potentially for all mem-
bers of the family given its high level of conservation. To
investigate this, we introduced a non-polar amino acid, ala-
nine, into position 395. The N395A mutation had less severe
e¡ects than the N395D mutation but still resulted in signi¢-
cant impairment of transporter function. If N395 did have a
direct role in transport due to its hydrogen bonding capacity
we would expect the N395A change to result in a complete
loss of function since alanine is unable to form hydrogen
Table 2
Properties of SHST1 mutants
Mutant strain Complementationa Km (WM)b Vbmax (nmol/min/mg protein)
YSD7(SHST1) +++ 9 þ 2 3.1 þ 0.3
YSD6 (pYES) 3 ^ 6 0.2
YSD24(E387Q) +++ 13 þ 4 0.5 þ 0.1
YSD23 (N395D) 3 ^ 6 0.2
YSD19(N395A) ++ 14 þ 5 0.4 þ 0.2
YSD22(L453P) +++ 14 þ 2 0.9 þ 0.2
The values shown are the mean þ S.D. from at least three independent experiments.
aComplementation of YSD1 by each mutant plasmid as indicated by growth on minimal galactose plates supplemented with 100 WM sulphate.
+++, wild type growth; ++, moderate growth; +, poor growth; 3, no growth.
bCells were incubated for 2 min in the presence of a range of concentrations of [35S]sulphate. The Michaelis^Menten equation was ¢tted to the
data.
Fig. 2. Growth curves of mutant and control strains on minimal ga-
lactose medium with 100 WM sulphate as the sole source of sulphur.
Each curve is the mean of three experiments, with standard error
of the mean indicated. Error bars are shown only if they are
larger than the symbol. YSD7(SHST1), F ; YSD6(pYES), O ;
YSD24(E387Q), R ; YSD19(N395A), a ; YSD23(N395D), E ;
YSD22(L453P), b.
Fig. 3. Western blot of plasma membrane protein from mutant
yeast strains. Cells were grown and plasma membranes prepared as
described in Section 2. Plasma membrane proteins were separated
by SDS^PAGE, transferred to nitrocellulose and probed with poly-
clonal antisera to SHST1. Lane 1, YSD6(pYES); lane 2,
YSD7(SHST1); lane 3, YSD24(E387Q); lane 4, YSD19(N395A);
lane 5, YSD23(N395D); lane 6, YSD22(L453P). Lane 7 is the same
as lane 6 but is a shorter exposure of the blot to X-ray ¢lm.
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bonds. The retention of some activity rules out a direct mech-
anistic role for N395. Both sulphate transport and the level of
expression in the plasma membrane were very low for this
mutant. The major e¡ect of this mutation is therefore on
stability and/or tra⁄cking of the transporter. However, it is
possible that activity of the SHST1 in the plasma membrane
was also a¡ected by the mutation. N395 is likely to be in-
volved in interactions with other residues which contribute
to the stability and/or folding of the transporter. Helix 9 is
somewhat atypical in that it contains a number of other polar
residues as well as three glycine residues. This region may
therefore be quite £exible, and also has the potential for hy-
drogen bonding. It has recently been shown that glycine res-
idues within a transmembrane helix of the lactose permease
from E. coli are essential for function [17].
Despite the conservation of E387, it is apparently not nec-
essary for sulphate transport. Nevertheless, YSD24(E387Q)
had substantially reduced sulphate uptake activity and very
low expression of the mutant transporter in the plasma mem-
brane. This mutation, like N395A, appears to primarily a¡ect
normal tra⁄cking of SHST1 to the plasma membrane
although a direct e¡ect on sulphate uptake activity as well
cannot be excluded. E387 is located at the N-terminal end
of putative transmembrane helix 9. The similar phenotype
observed for the E387Q and N395A mutants suggests that
interactions of polar residues in this helix are important for
folding and/or stability of SHST1.
In conclusion, we have shown that two mutations of con-
served amino acids which a¡ect the human sulphate/chloride
exchanger encoded by the DTDST gene also a¡ect the func-
tion of the plant sulphate/proton symporter, SHST1. Further,
we have found that mutations in putative helix 9 primarily
a¡ect stability and/or tra⁄cking of SHST1. We are continuing
to use site-directed mutagenesis to elucidate the role of this
helix in the mechanism of sulphate transport.
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